AAAAAA
Results: 1-25/28
Authors:
Terreni, M
Villani, P
Citation: M. Terreni et P. Villani, New anti-Mycobacterium agents: recent advances in patent literature, EXPERT OP T, 11(2), 2001, pp. 261-268
Authors:
Regazzi, MB
Seminari, E
Villani, P
Carriero, PL
Montagna, M
Marubbi, F
Maserati, R
Citation: Mb. Regazzi et al., Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profile, J CHEMOTHER, 13(5), 2001, pp. 569-574
Authors:
Villani, P
Demet, D
Ambrosi, P
Brondino-Riquier, R
Bouvenot, G
Citation: P. Villani et al., Diagnostic and therapeutic management of urinary tract infections in medical wards in a Marseille University Hospital, PRESSE MED, 30(24), 2001, pp. 1204-1208
Authors:
Bruno, R
Regazzi, MB
Ciappina, V
Villani, P
Sacchi, P
Montagna, M
Panebianco, R
Filice, G
Citation: R. Bruno et al., Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV, CLIN PHARMA, 40(9), 2001, pp. 695-700
Authors:
Villani, P
Feroggio, M
Gianelli, L
Bartoli, A
Montagna, M
Maserati, R
Regazzi, MB
Citation: P. Villani et al., Antiretrovirals: Simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography-mass spectrometry assay, THER DRUG M, 23(4), 2001, pp. 380-388
Authors:
Villani, P
Viale, P
Signorini, L
Cadeo, B
Marchetti, F
Villani, A
Fiocchi, C
Regazzi, MB
Carosi, G
Citation: P. Villani et al., Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy, ANTIM AG CH, 45(7), 2001, pp. 2160-2162
Authors:
Seminar, E
Maggiolo, F
Villani, P
Suter, F
Pan, A
Regazzi, MB
Paolucci, S
Baldanti, F
Tinelli, C
Maserati, R
Citation: E. Seminar et al., Efavirenz, nelfiniavir, and stavudine rescue combination therapy in HIV-1-Positive patients heavily pretreated with nucleoside analogues and proteaseinhibitors (vol 22, pg 453, 1999), J ACQ IMM D, 23(3), 2000, pp. 278-278
Authors:
Villani, P
Altavista, PL
Castaldi, L
Leter, G
Cordelli, E
Citation: P. Villani et al., Analysis of DNA oxidative damage related to cell proliferation, MUT RES-GTE, 464(2), 2000, pp. 229-237
Authors:
Bouvenot, G
Villani, P
Citation: G. Bouvenot et P. Villani, Equivalence trials in rheumatology, JOINT BONE, 67(5), 2000, pp. 362-365
Authors:
Ambjorn, J
Carfora, M
Marzuoli, A
Villani, P
Citation: J. Ambjorn et al., Recent analytical results in 4D-dynamical triangulations, NUCL PH B-P, 83-4, 2000, pp. 745-747
Authors:
Ambrosi, P
Calise, G
Villani, P
Luccioni, R
Bouvenot, G
Citation: P. Ambrosi et al., Prescription of low-molecular-weight heparin for venous thromboembolism prophylaxis in medical patients, PRESSE MED, 29(26), 2000, pp. 1447-1450
Authors:
Villani, P
Citation: P. Villani, Classical and medieval literature criticism, Vol 26, Excerpts from criticism of the works of world authors from classical antiquity through the Fourteenth Century, from the first appraisals to current evaluations, ASIAN FOLK, 59(1), 2000, pp. 153-155
Authors:
Regazzi, MB
Villani, P
Maserati, R
Seminari, E
Pan, A
LoCaputo, F
Gambarana, E
Fiocchi, C
Citation: Mb. Regazzi et al., Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients, J ANTIMICRO, 45(3), 2000, pp. 343-347
Authors:
Maserati, R
Villani, P
Barasolo, G
Mongiovetti, M
Regazzi, MB
Citation: R. Maserati et al., Influenza immunization and indinavir pharmacokinetics, SC J IN DIS, 32(4), 2000, pp. 449-450
Authors:
Villani, P
Citation: P. Villani, Pierre Francois Lacheze and the Italian patriots - A French diplomat in Genoa in 1792, RASS STOR R, 87(1), 2000, pp. 21-40
Authors:
Seminari, E
Maggiolo, F
Villani, P
Suter, F
Pan, A
Regazzi, MB
Tinelli, C
Maserati, R
Citation: E. Seminari et al., Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors, J ACQ IMM D, 22(5), 1999, pp. 453-460
Authors:
Daffaud, F
Orsiere, T
Villani, P
Volot, F
Favre, R
Botta, A
Citation: F. Daffaud et al., Micronucleated lymphocyte rates from head-and-neck cancer patients, MUT RES-GTE, 439(2), 1999, pp. 259-266
Authors:
Villani, P
Mugnier, B
Bouvenot, G
Citation: P. Villani et al., Muscle cramps: reevaluation of the efficacy of quinine salts, PRESSE MED, 28(24), 1999, pp. 1309-1312
Authors:
Villani, P
Regazzi, MB
Castelli, F
Viale, P
Torti, C
Seminari, E
Maserati, R
Citation: P. Villani et al., Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients, BR J CL PH, 48(5), 1999, pp. 712-715
Authors:
Regazzi, MB
Villani, P
Maserati, R
Cocchi, L
Giacchino, R
Burroni, D
Rettani, M
Citation: Mb. Regazzi et al., Pharmacokinetic variability and strategy for therapeutic drug monitoring of saquinavir (SQV) in HIV-I infected individuals, BR J CL PH, 47(4), 1999, pp. 379-382
Authors:
Maserati, R
Villani, P
Seminari, E
Pan, A
Lo Caputo, S
Regazzi, MB
Citation: R. Maserati et al., High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease, AIDS, 13(7), 1999, pp. 870-871
Authors:
Villani, P
Pregnolato, M
Banfo, S
Rettani, M
Burroni, D
Seminari, E
Maserati, R
Regazzi, MB
Citation: P. Villani et al., High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma, THER DRUG M, 21(3), 1999, pp. 346-350
Authors:
Veneziano, D
Villani, P
Citation: D. Veneziano et P. Villani, Best linear unbiased design hyetograph, WATER RES R, 35(9), 1999, pp. 2725-2738
Authors:
Cordelli, E
Altavista, P
Leter, G
Castaldi, L
Villani, P
Citation: E. Cordelli et al., Analysis of oxidative damage in cells in different phases of the cell cycle, NEOPLASMA, 46, 1999, pp. 44-45
Authors:
Villani, P
Citation: P. Villani, World mythology: An annotated guide to collections and anthologies, ASIAN FOLK, 57(1), 1998, pp. 150-152